Primary objectives: * To estimate Sexual Dysfunction (SD) incidence in premenopausal breast cancer patients treated by surgery and taking endocrine therapy. * To detect the presence of SD-related distress in the population, as a determining factor in the maintenance of a good quality of life. Secondary objectives: * To describe SD characteristics determining the most frequently reported symptoms and correlations with type of surgery or therapeutic regimens. * Collect baseline data for subsequent randomized trials involving practical interventions with the aim to reduce SD prevalence in this population.
Study Type
OBSERVATIONAL
Enrollment
150
none, it's a incidence-prevalence study
IRCCS Candiolo Cancer Center
Torino, TO, Italy
RECRUITINGSexual Dysfunction (SD) incidence
To estimate Sexual Dysfunction (SD) incidence (physiological parameter) in premenopausal breast cancer patients treated by surgery and taking endocrine therapy.
Time frame: 6 months
SD-related distress
To detect the presence of SD-related distress (physiological parameter) in the population, as a determining factor in the maintenance of a good quality of life.
Time frame: 6 months
SD characteristics
To describe SD characteristics determining the most frequently reported symptoms and correlations with type of surgery or therapeutic regimens.
Time frame: 6 months
Collect baseline data
Collect baseline data for subsequent randomized trials involving practical interventions with the aim to reduce SD prevalence in this population.
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.